Status:
COMPLETED
The Turkish Version Of The Brief-Caffeine Expectancy Questionnaire
Lead Sponsor:
Eskisehir Technical University
Conditions:
Caffeine
Adaptation
Eligibility:
All Genders
18-60 years
Brief Summary
Caffeine is a psycho-active substance that is widely consumed in the world. It is seen that its widespread consumption is related to expectancies of consumption as well as cultural factors. Recreation...
Detailed Description
INTRODUCTION Caffeine (1,3,7-trimethylxanthine) is most commonly found in coffee as the main pharmacologically active ingredient. In general, brewed coffee has the highest content among foodstuffs co...
Eligibility Criteria
Inclusion
- Aged between 18 and 60
- Physical health individuals
Exclusion
- Heart disease
- Using of pacemaker
- Epilepsy
- Transient ischemic attack
- Stroke or similar nervous disorders
- Psychiatric disease
- Cardio-pulmonary diseases
- Pregnancy
- Drug using that affect the heart rate and blood pressure
- Systemic, neuroplastic, inflammation disorders
Key Trial Info
Start Date :
September 8 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06038903
Start Date
September 8 2023
End Date
October 15 2023
Last Update
February 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eskişehir Technical University
Eskişehir, Tepebaşı, Turkey (Türkiye), 26555